{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-110375","form_type":"8-K","ticker":"MXCT","cik":"0001287098","company_name":"MAXCYTE, INC.","filed_at":"2025-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.032871+00:00","generated_at":"2026-05-16T20:56:25.431719+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"MaxCyte Q3 revenue down 16% YoY to $6.8M; reiterates FY2025 guidance","bullets":["Total revenue $6.8M (-16% YoY); core revenue $6.4M (-21% YoY).","Net loss $12.4M vs $11.6M loss in Q3 2024; adjusted EBITDA loss $10.0M.","Added 4 new SPL clients in 2025 (latest Moonlight Bio in Oct); total SPLs now 32.","Reiterates FY2025 guidance: core revenue flat/-10% YoY; SPL program revenue ~$5M.","Operational restructuring announced Sep 22 to reduce costs; cash at $158M."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-110375","json":"https://secwatch.observer/filing/0001104659-25-110375.json","markdown":"https://secwatch.observer/filing/0001104659-25-110375.md","text":"https://secwatch.observer/filing/0001104659-25-110375.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1287098/000110465925110375/0001104659-25-110375-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1287098/000110465925110375/mxct-20251112x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T20:56:25.431719+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}